The prevalence of overweight and obesity is higher in people with mental illness than in the
general population. Body weight is tightly regulated by a complex system involving the …

Overweight and obesity are highly prevalent in patients with bipolar disorder, and metabolic
disorders also affect a significant portion of this population. Obesity and metabolic disorders …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) published guidelines
for the management of bipolar disorder in 2005, with a 2007 update. This second update, in …

Bipolar disorder (BD) has been classically described as one of episodic mood disturbances.
New evidence suggests that a chronic course and multisystem involvement is the rule, rather …

Second-generation antipsychotics (SGA) are associated with weight gain and metabolic
alterations including hyperglycemia, dyslipidemia, hypertension and metabolic syndrome …

Therapeutic use of atypical antipsychotic agents is often associated with weight gain and
impaired glucose tolerance. The once-daily human GLP-1 analog liraglutide improves …

Psychiatric and metabolic disorders are highly comorbid and the relationship between these
disorders is bidirectional. The mechanisms underlying the association between psychiatric …

Objective: We aimed to assess the resting energy expenditure in bipolar I disorder, manic
episode patients. Method: Forty‐two bipolar I disorder, manic episode patients that were …

People with severe mental illness (SMI), including schizophrenia and related psychoses and
bipolar disorder, are at greater risk for obesity compared with people without mental illness …

Objective To investigate the effect of risperidone on energy expenditure and weight gain in
female C57BL/6J mice. Design and Methods Body weight and composition, food intake …